• About
  • Advertise
  • Jobs
Sunday, September 13, 2026
No Result
View All Result
KashmirPEN
  • Home
  • Latest NewsLive
  • State News
  • COVID-19
  • Kashmir
  • National
  • International
  • Education
  • Sports
  • Entertainment
  • Technology
  • Weekly
    • Perception
    • Perspective
    • Narrative
    • Concern
    • Nostalgia
    • Tribute
    • Viewpoint
    • Outlook
    • Opinion
    • Sufi Saints of Kashmir
    • Personality
    • Musing
    • Society
    • Editorial
    • Analysis
    • Culture
    • Cover Story
    • Book Review
    • Heritage
    • Art & Poetry
  • Home
  • Latest NewsLive
  • State News
  • COVID-19
  • Kashmir
  • National
  • International
  • Education
  • Sports
  • Entertainment
  • Technology
  • Weekly
    • Perception
    • Perspective
    • Narrative
    • Concern
    • Nostalgia
    • Tribute
    • Viewpoint
    • Outlook
    • Opinion
    • Sufi Saints of Kashmir
    • Personality
    • Musing
    • Society
    • Editorial
    • Analysis
    • Culture
    • Cover Story
    • Book Review
    • Heritage
    • Art & Poetry
KashmirPEN
No Result
View All Result
ADVERTISEMENT
Home Latest News

Govt panel suggests increasing gap between two doses of Covishield

Kashmir Pen by Kashmir Pen
5 years ago
in Latest News, National
Reading Time: 1 min read
Prioritise beneficiaries for 2nd dose, reserve 70% vax for them: Govt to States/UTs
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

The National Technical Advisory Group on Immunisation (NTAGI) has recommended increasing the gap between two doses of Covishield vaccine to 12-16 weeks, sources said on Thursday.

It has also suggested that pregnant women may be offered the choice to take any COVID-19 vaccine and that lactating women can be inoculated any time after delivery.

The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.

ADVERTISEMENT

Currently, the interval between two doses of Covishield is four to eight weeks. No change in dosage interval for Covaxin has been suggested by the panel.

The recommendations of the NTAGI will be sent to the National Expert Group on Vaccine Adminstration for COVID-19. ( PTI )

Previous Post

COVID-19:India logs 3.62 lakh new cases, 4,120 fresh fatalities

Next Post

Nowhere to run : Fear in Gaza grows amid conflict with Israel

Kashmir Pen

Kashmir Pen

Next Post
Death Toll from Israel Airstrikes Climbs to 43, Including 13 Children : Gaza Health Min

Nowhere to run : Fear in Gaza grows amid conflict with Israel

Leave Comment
ADVERTISEMENT
Facebook Twitter Youtube RSS

©2020 KashmirPEN | Made with ❤️ by Uzair.XYZ

No Result
View All Result
  • Home
  • Latest News
  • State News
  • COVID-19
  • Kashmir
  • National
  • International
  • Education
  • Sports
  • Entertainment
  • Technology
  • Weekly
    • Perception
    • Perspective
    • Narrative
    • Concern
    • Nostalgia
    • Tribute
    • Viewpoint
    • Outlook
    • Opinion
    • Sufi Saints of Kashmir
    • Personality
    • Musing
    • Society
    • Editorial
    • Analysis
    • Culture
    • Cover Story
    • Book Review
    • Heritage
    • Art & Poetry

©2020 KashmirPEN | Made with ❤️ by Uzair.XYZ